The US Food and Drug Administration (FDA) this week began adding four-letter meaningless suffixes at the end of newly approved biologics' nonproprietary names, signaling a shift in policy from only ...
Will FDA Add Suffixes to Approved Biologics' Names? Back in January, the US Food and Drug Administration (FDA) finalized guidance on how biosimilars and their biologic reference products' names should ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results